Clinical Trial Update: BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study [Phase 4]

View source ↗

Summary

Clinical trial update for the STAR study evaluating switching to TAF-based antiretroviral therapy in adults with bone loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss

Drugs mentioned

• TAF-based antiretroviral therapy

Snippet

Sponsor: MU-JHU CARE | Conditions: Bone Loss | Phase 4 | Status: UNKNOWN